BILLS-110hr3580enr.pdf

2007 annual later than 30 days fiscal year 2008 later than 1 year 30 days fiscal year a fiscal year fiscal year 2009 later than 180 days 30-day fiscal year 2012 1 year fiscal year 2011 later than 90 days 2012 each fiscal year fiscal years later than 18 months fiscal year 2010 October 1, 2012 the fiscal year annually 2 years fiscal years 2008 through 2012 October 1, 2007 the day before the date 180-day 2010 2003 120 days later than 9 months 2002 fiscal year 2008 90 days fiscal year 2007 the fiscal years 2008 12-month 2009 fiscal year 18 months such fiscal year fiscal year 2009 later than 120 days 180 days seven years more than 30 days 15 days 1997

the ‘‘Food and Drug Administration the ‘‘Act the ‘‘Administrative Procedure Act the ‘‘Best Pharmaceuticals the ‘‘Medical Device User Fee Amendments the ‘‘Pediatric Medical Device Safety the ‘‘Pediatric Research Equity Act

the United States United States United States the United States the District of Columbia States United Founda- d)(2)(A)(ii United States of America Washington U.S. the City of the District of Columbia Circuit TIMETABLES the United States of America CONTENTS.—A

SAME.—If

510(k non-racemic Congressional lish RESULTS.—The APPROVAL.—Each American Indian African FUNDING.—The i)(I)(bb AGREEMENTS.—The tories

SEC the Federal Food, Drug the Food and Drug Administration U.S.C. Congress the Public Health Service Act Senate the Food and Drug Administration Drug Administration Labor the Food and Drug Administra- NIH the Federal Food, Drug the Federal Food Drug Food and Drug Administration the National Institutes of Health Federal Food, Drug Health and Human Services State the House of Representatives the Public Health Service the Food and Drug Administration Amendments Act Foundation DTC the Federal Register the Committee on Health, Education the Commissioner of Food and Drugs the Pediatric Advisory Committee Food and Drugs the Best Pharmaceuticals for Children Act the Food and Drug Adminis- Board the Federal Register the Public Health Service Act House National Institutes of Health House of Representatives the Comptroller General the Pediatric Research Equity Act GENERAL.—If Energy and Commerce FDA the Committee on Health, Education Human Services the Committee on Energy and Commerce the Committee on Energy and Commerce of the National Institutes of Health Healthcare the Best Pharmaceuticals for Children Act

H. R. Reagan H. R. 3580—47 H. R. 3580—82 H. R. 3580—64 H. R. 3580—24 H. R. 3580—137 H. R. 3580—102 H. R. 3580—36 H. R. 3580—42 H. R. 3580—89 H. R. 3580—72 H. R. 3580—40 H. R. 3580—67 H. R. 3580—63 H. R. 3580—10 H. R. 3580—131 H. R. 3580—74 REPORTS.—Each H. R. 3580—16 H. R. 3580—96 H. R. 3580—101 H. R. 3580—112 H. R. 3580—139 H. R. 3580—25 H. R. 3580—39 H. R. 3580—31 H. R. 3580—54 H. R. 3580—150 H. R. 3580—35 H. R. 3580—94 H. R. 3580—155 H. R. 3580—61 H. R. 3580—13 H. R. 3580—20 H. R. 3580—86 H. R. 3580—88 H. R. 3580—45 H. R. 3580—3 H. R. 3580—130 H. R. 3580—103 H. R. 3580—153 Medicine H. R. 3580—37 H. R. 3580—93 H. R. 3580—99 H. R. 3580—2 H. R. 3580—26 H. R. 3580—95 randa H. R. 3580—107

postmarket pediatric drugs emission user fee drug fee amendments drugs sec medical devices devices sec fee device food drug references title refused